InsiderTrades.com logo

ATYR Insider Trading

Insider Ownership Percentage: 3.70%
Insider Buying (Last 12 Months): $172,369.48
Insider Selling (Last 12 Months): $0.00

Atyr PHARMA Insider Trading History Chart

This chart shows the insider buying and selling history at Atyr PHARMA by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Atyr PHARMA Share Price & Price History

Current Price: $3.63
Price Change: ▲ Price Increase of +0.02 (0.55%)
As of 01/21/2025 05:00 PM ET

This chart shows the closing price history over time for ATYR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Atyr PHARMA Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/24/2024Paul SchimmelDirectorBuy52,300$1.93$100,939.00413,023View SEC Filing Icon  
7/22/2024Paul SchimmelDirectorBuy41,052$1.74$71,430.48354,075View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Atyr PHARMA (NASDAQ:ATYR)

61.72% of Atyr PHARMA stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Atyr PHARMA Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
1/1/2025JPMorgan Chase & Co.31,440$55K0.0%+52.0%0.037%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Atyr PHARMA logo
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
Read More on Atyr PHARMA

Today's Range

Now: $3.63
Low: $3.46
High: $3.65

50 Day Range

MA: $3.40
Low: $2.91
High: $3.98

52 Week Range

Now: $3.63
Low: $1.42
High: $4.22

Volume

558,756 shs

Average Volume

997,107 shs

Market Capitalization

$304.70 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.08

Who are the company insiders with the largest holdings of Atyr PHARMA?

Atyr PHARMA's top insider shareholders include:
  1. Paul Schimmel (Director)
Learn More about top insider investors at Atyr PHARMA.